Patrizia Giannatempo: Great ESMO 2026 Discussion on Personalising MIBC Treatment
Patrizia Giannatempo/ X

Patrizia Giannatempo: Great ESMO 2026 Discussion on Personalising MIBC Treatment

Patrizia Giannatempo, Medical oncologist at Gemelli Polyclinic Foundation IRCCS, shared on X:

“Great discussion on escalation and de-escalation in MIBC at ESMO26! Not ready to de-escalate outside trials, but ready to personalise treatment.

We’re getting closer!”

Patrizia Giannatempo: Great ESMO 2026 Discussion on Personalising MIBC Treatment

You can also read:

VOLGA at ESMO 2026: Perioperative Durvalumab With or Without Tremelimumab Plus Enfortumab Vedotin in MIBC

Patrizia Giannatempo: Great ESMO 2026 Discussion on Personalising MIBC Treatment